BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29105375)

  • 1. Role of Nursing Competencies for Accelerating Clinical Trials in Stem Cell Clinics.
    Perrin M; Kim T; Stan R; Giesie P; Tabor J; Le Verche V; Johnson S; Lomax GP; Zaia JA
    Stem Cells Transl Med; 2018 Jan; 7(1):6-10. PubMed ID: 29105375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges.
    Jamieson CHM; Millan MT; Creasey AA; Lomax G; Donohoe ME; Walters MC; Abedi M; Bota DA; Zaia JA; Adams JS
    Cell Stem Cell; 2018 Jun; 22(6):801-805. PubMed ID: 29859170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regen Med California Institute for Regenerative Medicine Profile CIRM 2.0.
    McCormack K
    Regen Med; 2016 Dec; 11(8):759-762. PubMed ID: 27908225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational strategies and challenges in regenerative medicine.
    Dimmeler S; Ding S; Rando TA; Trounson A
    Nat Med; 2014 Aug; 20(8):814-21. PubMed ID: 25100527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating stem cell therapies: the role of companion animals in regenerative medicine.
    Volk SW; Theoret C
    Wound Repair Regen; 2013; 21(3):382-94. PubMed ID: 23627495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The stem cell and its context. Between the will to power and the will to relationship.].
    Ribatti D
    Recenti Prog Med; 2024 Jun; 115(6):286-289. PubMed ID: 38853731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. California institute for regenerative medicine: accelerating stem cell therapies in California and beyond.
    Trounson A
    Stem Cells; 2012 Mar; 30(3):357-9. PubMed ID: 22334457
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIRM tools and technologies: Breaking bottlenecks to the development of stem cell therapies.
    Collins LR; Shepard KA
    Stem Cells Transl Med; 2020 Oct; 9(10):1129-1136. PubMed ID: 32619326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.
    Roy DC; Alarco AM; Isasi R
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells: promises versus limitations.
    Choumerianou DM; Dimitriou H; Kalmanti M
    Tissue Eng Part B Rev; 2008 Mar; 14(1):53-60. PubMed ID: 18454634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging stem cell based strategies for treatment of childhood diseases.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):311-315. PubMed ID: 29793820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative cellular therapies for neurologic diseases.
    Levy M; Boulis N; Rao M; Svendsen CN
    Brain Res; 2016 May; 1638(Pt A):88-96. PubMed ID: 26239912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Cell Therapies in Regenerative Medicine and Cancers.
    Lin SZ
    Cell Transplant; 2016; 25(5):781-2. PubMed ID: 27102174
    [No Abstract]   [Full Text] [Related]  

  • 15. Steady advance of stem cell therapies: report from the 2011 World Stem Cell Summit, Pasadena, California, October 3-5.
    Swan M
    Rejuvenation Res; 2011 Dec; 14(6):699-704. PubMed ID: 22175514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative stem cell therapy.
    Coelho MB; Cabral JM; Karp JM
    Annu Rev Biomed Eng; 2012; 14():325-49. PubMed ID: 22809140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry updates from the field of stem cell research and regenerative medicine in February 2020.
    Ilic D; Liovic M
    Regen Med; 2020 Jun; 15(6):1689-1694. PubMed ID: 32290767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue and stem/progenitor cells: discovery and development.
    Kapur SK; Dos-Anjos Vilaboa S; Llull R; Katz AJ
    Clin Plast Surg; 2015 Apr; 42(2):155-67. PubMed ID: 25827560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State stem cell agency floats idea of $70 million 'Alpha' clinics.
    Dolgin E
    Nat Med; 2013 Jul; 19(7):798. PubMed ID: 23836206
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cutting-edge of medicine: progress and prospects: induced pluripotent stem cell research for neurological diseases].
    Ito D; Suzuki N
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3230-6. PubMed ID: 24605575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.